Clearbridge Health Ltd
1H3
Company Profile
Business description
Clearbridge Health Ltd provides health care services. It is an integrated healthcare group with end-to-end diagnostic abilities, deploying non-invasive tests to identify and manage illness. The segments are Strategic investments; Others ; Medical clinics; Corporate segment and Investment. It derives key revenue from the Medical clinics segment. The medical clinics/centres segment involves the provision of general medical, dental and clinical services and distribution of the medical and pharmaceutical products. The group has a business presence in Singapore, Philippines, Hong Kong, Malaysia and others.
Contact
37 Jalan Pemimpin
No. 08-05 Mapex
Singapore577177
SGPT: +65 62510136
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2026
Employees
115
Stocks News & Analysis
stocks
Chart of the Week: BHP’s valuation hits historic levels
BHP and peers are trading as if the copper boom is here to stay.
stocks
3 cheap wide moat growth stocks
4 and 5 star companies that can protect and grow their earnings.
stocks
ASX biotech expands diagnostics portfolio after FDA approval
FDA nod adds another growth driver for ASX share.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,910.90 | 36.40 | 0.41% |
| CAC 40 | 8,189.01 | 48.42 | 0.59% |
| DAX 40 | 25,737.65 | 199.90 | 0.78% |
| Dow JONES (US) | 51,732.36 | 270.46 | 0.53% |
| FTSE 100 | 10,814.23 | 125.76 | 1.18% |
| HKSE | 24,604.29 | 109.49 | -0.44% |
| NASDAQ | 26,367.47 | 389.05 | 1.50% |
| Nikkei 225 | 64,136.25 | 213.25 | 0.33% |
| NZX 50 Index | 13,756.59 | 133.87 | 0.98% |
| S&P 500 | 7,624.80 | 72.99 | 0.97% |
| S&P/ASX 200 | 8,732.40 | 35.90 | 0.41% |
| SSE Composite Index | 3,875.60 | 16.00 | -0.41% |